April 25 (Reuters) - The U.S. health regulator has sent a warning letter to Cardinal Health (CAH.N), opens new tab after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer.
Drug distributor Cardinal Health to lose OptumRx contracts
Cardinal Health to acquire Specialty Networks and its PPS Analytics platform
Enforcement Report - Week of November 29, 2023
Nov 20 (Reuters) - The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's (CAH.N) Monoject syringes with patient-controlled pain management pumps and syringe pumps.
Nov 3 (Reuters) - Drug distributor Cardinal Health (CAH.N) on Friday raised its full-year earnings forecast for the second time in nearly three months, betting on strong demand for specialty medicines.
Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
FDA advises not to purchase certain eye drops due to infection risk
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that on June 14, 2023 it entered into an amendment (the “Amendment”) to the Asset Purchase Agreement, dated November 23, 2016 (the “Purchase Agreement”), between the Company and Cardinal Health 414, LLC (“Cardinal Health 414”), an affiliate of Cardinal Health, Inc. (NYSE: CAH). Under the terms of the Amendment, Cardinal Health 414 paid the Company $7.5 million in cash on June 14, 2023 and the Company waived its right to receive any contingent Milestone Payment that might otherwise become due and payable under the Purchase Agreement. The cash payment from Cardinal Health 414 provides immediate capital for the Company’s Phase IIb (NAV3-32) and Phase III (NAV3-33) trials and related operations. Building on a history of partnership between the Company and Cardinal Health, the Amendment also aligns and supports growth goals related to LYMPHOSEEK® for both organizations.
SYDNEY, May 4 (Reuters) - Australia's Labor government on Thursday said it would set aside A$11.3 billion ($7.5 billion) in next week's federal budget to fund a 15% pay rise for retirement home staff as the sector grapples with a shortage of skilled workers.